Onglyza Q&A

1.  What is Onglyza?

  1. Onglyza is a medication used to help control high blood sugar in people with Type 2 diabetes who do not suffer from diabetic ketoacidosis.

2.  Who is the manufacturer of Onglyza?

  1. Onglyza is manufactured by AstraZeneca

3.  Is Onglyza approved by the FDA?

  1. Yes. Onglyza was approved by the FDA in 2009.

4.  How does Onglyza work?

  1. Onglyza belongs to a class of drugs known as DPP-4 inhibitors. This DPP-4 inhibitor is an incretin-based therapy that helps the pancreas secrete more insulin and stop the liver from making excess sugar.

5.  What are the complications associated with taking Onglyza?

  1. Onglyza can cause an array of side effects, some benign and some very serious.
  2. The more common side effects include:
    1. Diarrhea
    2. Headache
    3. Nausea and vomiting
    4. Sore throat
    5. UTI
    6. Stuffy or runny nose
    7. Low blood sugar
    8. Swelling or fluid retention.
  3. More serious complications include:
    1. Heart complications, including heart failure
    2. Pancreatic cancer
    3. Pancreatitis
    4. Thyroid cancer
    5. Bladder cancer

6.  Why are lawsuits being filed by consumers?

  1. Lawsuits are being filed against the manufacturer of Onglyza because of the serious complications the medication can cause and the lack of a proper warning of those complications.

7.  Where can I go for help?

  1. If you or a loved one has taken Onglyza and suffered heart failure and/or death, you may have a case for compensation against AstraZeneca. At Reich & Binstock, we are here to help. Contact our lawyers for a free and confidential case evaluation. Call 1-866-LAW-2400 or complete the contact form on this website.
Read More